Core Neuro Health says the pairing cut close to a quarter of body weight in trial participants. Eloralintide is an experimental drug aimed at an appetite hormone.
Recap by typeshit. Post by @coreneurohealth1 on Instagram.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
A SURPASS-4 analysis at ASN Kidney Week 2026 found rapid kidney decline in 5% on tirzepatide versus 13% on insulin glargine, with the biggest gains in high protein groups.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
The account credits the FDA with the claim and says it uses retatrutide prescribed in Costa Rica. No FDA statement or details are included.
The ABC7 Los Angeles health reporter looks at how dentists are using one peptide in patients' oral care.
Loading…